Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jun;7(6):E743-E750.
doi: 10.1055/a-0839-4514. Epub 2019 May 17.

Even non-experts identify non-dysplastic lesions in inflammatory bowel disease via chromoendoscopy: results of a screening program in real-life

Beatriz Sicilia Aladrén  1 , Yago González-Lama  2 , María García-Alvarado  3 , Mónica Sierra  4 , Jésus Andrés Barrio  5 , Vanesa Prieto Vicente  6 , Luis Hernández  7 , Benito Velayos  8 , Lara Arias Garcia  1 , Lucia Relea  2 , Patricia Suarez  4 , Ramón Atienza  5 , Mónica Vásquez  7 , Luis Fernández-Salazar  8 , Fernando Muñoz  6 ; GEICYL (group of inflammatory bowel disease of Castilla y León)
Affiliations

Even non-experts identify non-dysplastic lesions in inflammatory bowel disease via chromoendoscopy: results of a screening program in real-life

Beatriz Sicilia Aladrén et al. Endosc Int Open. 2019 Jun.

Abstract

Background and study aims Chromoendoscopy with targeted biopsy is the technique of choice for colorectal cancer screening in longstanding inflammatory bowel disease. We aimed to analyze results of a chromoendoscopy screening program and to assess the possibility of identifying low-risk dysplastic lesions by their endoscopic appearance in order to avoid histological analysis. Materials and methods We retrospectively reviewed chromoendoscopies performed between February 2011 and June 2017 in seven Spanish hospitals in a standardized fashion. We analyzed the findings and the diagnostic yield of the Kudo pit pattern for predicting dysplasia. Results A total of 709 chromoendoscopies (569 patients) were reviewed. Median duration of disease was 16.7 years (SD 8.1); 80.4 % had ulcerative colitis. A total of 2025 lesions (3.56 lesions per patient) were found; two hundred and thirty-two lesions were neoplastic (11.5 %) (223 were LGD (96.1 %), eight were HGD (3.4 %), and one was colorectal cancer (0.5 %). The correlation between dysplasia and Kudo pit patterns predictors of dysplasia (≥ III) was low, with an area under the curve of 0.649. Kudo I and II lesions were correctly identified with a high negative predictive value (92 %), even by non-experts. Endoscopic activity, Paris 0-Is classification, and right colon localization were risk factors for dysplasia detection, while rectum or sigmoid localization were protective against dysplasia. Conclusions Chromoendoscopy in the real-life setting detected 11 % of dysplastic lesions with a low correlation with Kudo pit pattern. A high negative predictive value would prevent Kudo I and, probably, Kudo II biopsies in the left colon, reducing procedure time and avoiding complications.

PubMed Disclaimer

Conflict of interest statement

Competing interests None

Figures

Fig. 1
Fig. 1
Study flowchart.
Fig. 2
Fig. 2
Correlation between Kudo pit pattern and histological analysis.
Fig. 3
Fig. 3
Correlation between Kudo pit pattern and histological analysis in the first 50 chromoendoscopies at the most experience center.
Fig. 4
Fig. 4
Correlation between Kudo pit pattern and histological analysis in the last 50 chromoendoscopies.
See this image and copyright information in PMC

References

    1. Jess T, Gamborg M, Matzen P et al.Increased risk of intestinal cancer in Crohn’s disease: a meta-analysis of population-based cohort studies. Am J Gastroenterol. 2005;100:2724–2729. - PubMed
    1. Castaño-Milla C, Chaparro M, Gisbert J P. Systematic review with meta-analysis: the declining risk of colorectal cancer in ulcerative colitis. Aliment Pharmacol Ther. 2014;39:645–659. - PubMed
    1. Magro F, Gionchetti P, Eliakim R et al.European Crohn’s and Colitis Organisation. Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders. J Crohn Colitis. 2017;11:649–670. - PubMed
    1. Loftus E V., JrDoes monitoring prevent cancer in inflammatory bowel disease? J Clin Gastroenterol 20033605S79–83.; discussion S94-96 - PubMed
    1. Collins P D, Mpofu C, Watson A J et al.Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease. Cochrane Database Syst Rev. 2006:CD000279. - PubMed